![Colin Scott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colin Scott
Keine laufenden Positionen mehr
Profil
Colin Scott was Vice President of Clinical Research and Development for NovaBay Pharmaceuticals, Inc. from January 2006 to December 31, 2008.
From October 2004 to December 2005, he was Vice President-Drug Development for GlycoMimetics.
From June 2004 to September 2004, Dr. Scott was a Consultant to several biopharmaceutical companies.
From September 2002 to May 2004, he served as the Vice President-Clinical and Regulatory at Arriva Pharmaceuticals, Inc. From March 2001 to May 2002, Dr. Scott served as Vice President-Clinical of Emisphere Technologies, Inc. He received a Medical degree in Pulmonology and Infectious Diseases from Glasgow University in Scotland.
Ehemalige bekannte Positionen von Colin Scott
| Unternehmen | Position | Ende |
|---|---|---|
| STABLECOIN DEVELOPMENT CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2008 |
GlycoMimetics, Inc.
 GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Corporate Officer/Principal | 01.12.2005 |
Arriva Pharmaceuticals, Inc.
 Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2004 |
| EMISPHERE TECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2002 |
Ausbildung von Colin Scott
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Arriva Pharmaceuticals, Inc.
Arriva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory therapies for treating respiratory diseases | Health Technology |
NovaBay Pharmaceuticals, Inc.
 NovaBay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and sale of eye and wound care products | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
